Provided by Tiger Fintech (Singapore) Pte. Ltd.

Arrowhead Pharmaceuticals

20.71
-0.6200-2.91%
Volume:953.90K
Turnover:20.13M
Market Cap:2.86B
PE:-18.19
High:21.65
Open:21.42
Low:20.66
Close:21.33
52wk High:27.34
52wk Low:9.57
Shares:138.26M
Float Shares:118.91M
Volume Ratio:0.48
T/O Rate:0.80%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.1384
EPS(LYR):-5.0048
ROE:-37.11%
ROA:-5.96%
PB:5.48
PE(LYR):-4.14

Loading ...

Aug 15, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 13, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 13, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 07, 2025

Major Issues Report

Form 8-K - Current report
Aug 07, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 10, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 13, 2025

Major Issues Report

Form 8-K - Current report
May 12, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 15, 2025

Major Issues Report

Form 8-K - Current report
Apr 11, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 10, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 09, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 19, 2025

Major Issues Report

Form 8-K - Current report
Mar 13, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 04, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 10, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Feb 10, 2025

Major Issues Report

Form 8-K - Current report
Feb 07, 2025

Major Issues Report

Form 8-K - Current report
Jan 23, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities